不可手术肺癌患者的居家多学科康复:一项随机对照试验
这项平行组、评估者盲法、分配隐藏的随机对照试验纳入92例不可手术肺癌患者,比较常规护理加8周居家有氧与抗阻运动及行为改变和症状支持与单纯常规护理。意向性分析显示两组6分钟步行距离在9周(p=0.308)和6个月(p=0.979)均无显著差异,但干预组6个月时报告的生活质量和症状严重程度有显著改善。
要点
- 居家康复未改善不可手术肺癌患者的功能运动能力。
- 6个月时干预组患者报告的生活质量和症状严重程度显著改善。
- 主要终点阴性提示需重新审视康复目标与评价指标。
核心结论
- 居家康复未改善不可手术肺癌患者的功能运动能力,但6个月时患者报告的生活质量和症状严重程度有改善。
研究设计与样本
- 平行组、评估者盲法、分配隐藏的随机对照试验,92例不可手术肺癌患者按1:1分配至常规护理加8周有氧与抗阻运动联合行为改变策略和症状支持组(干预组)或单纯常规护理组。
- 评估在基线、9周和6个月进行,主要结局为组间6分钟步行距离变化,采用意向性分析。
主要发现
- 意向性分析显示两组6分钟步行距离在9周(p=0.308)和6个月(p=0.979)均无显著差异。
- 符合方案分析(至少一次随访)的6分钟步行距离组间差异仍无统计学意义:9周平均差-25.4米(95%CI -64.0至13.3),p=0.198;6个月41.3米(95%CI -26.7至109.4),p=0.232。
- 6个月时干预组在生活质量(FACT-Lung:13.0,95%CI 3.9至22.1,p=0.005)和症状严重程度(MDASI-Lung:-2.2,95%CI -3.6至-0.9,p=0.001)方面有显著改善。
临床怎么用
- 对不可手术肺癌患者,居家康复可作为改善生活质量和减轻症状负担的辅助手段,但不应以提升运动能力为主要预期目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung cancer is associated with poor health-related quality of life (HRQoL) and high symptom burden. This trial aimed to assess the efficacy of home-based rehabilitation versus usual care in inoperable lung cancer. METHODS: A parallel-group, assessor-blinded, allocation-concealed, randomised controlled trial. Eligible participants were allocated (1:1) to usual care (UC) plus 8 weeks of aerobic and resistance exercise with behaviour change strategies and symptom support (intervention group (IG)) or UC alone. Assessments occurred at baseline, 9 weeks and 6 months. The primary outcome, change in between-group 6 min walk distance (6MWD), was analysed using intention-to-treat (ITT). Subsequent analyses involved modified ITT (mITT) and included participants with at least one follow-up outcome measure. Secondary outcomes included HRQoL and symptoms. RESULTS: Ninety-two participants were recruited. Characteristics of participants (UC=47, IG=45): mean (SD) age 64 (12) years; men 55%; disease stage n (%) III=35 (38) and IV=48 (52); radical treatment 46%. There were no significant between-group differences for the 6MWD (n=92) at 9 weeks (p=0.308) or 6 months (p=0.979). The mITT analyses of 6MWD between-group differences were again non-significant (mean difference (95% CI): 9 weeks: -25.4 m (-64.0 to 13.3), p=0.198 and 6 months: 41.3 m (-26.7 to 109.4), p=0.232). Significant 6-month differences, favouring the IG, were found for HRQoL (Functional Assessment of Cancer Therapy-Lung: 13.0 (3.9 to 22.1), p=0.005) and symptom severity (MD Anderson Symptom Inventory-Lung Cancer: -2.2 (-3.6 to -0.9), p=0.001). CONCLUSIONS: Home-based rehabilitation did not improve functional exercise capacity but there were improvements in patient-reported exploratory secondary outcomes measures observed at 6 months. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ACTRN12614001268639).
引用
- Edbrooke L, Aranda S, Granger CL, et al. Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial. Thorax. 2019. PMID: 31048509. doi:10.1136/thoraxjnl-2018-212996
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。